Lantheus

$13.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-1.66%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Lantheus and other stocks, options, and ETFs commission-free!

About LNTH

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA. The listed name for LNTH is Lantheus Holdings, Inc. Common Stock.

CEO
Mary Anne Heino
Employees
508
Headquarters
North Billerica, Massachusetts
Founded
1956
Market Cap
869.33M
Price-Earnings Ratio
150.64
Dividend Yield
Average Volume
603.80K
High Today
$13.20
Low Today
$12.93
Open Price
$13.06
Volume
571.29K
52 Week High
$21.42
52 Week Low
$8.67

Collections

LNTH Earnings

$0.00
$0.12
$0.24
$0.36
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 23, Pre-Market

You May Also Like